Free Trial
→ Is this Elon’s true agenda? (From Altimetry) (Ad) Free CARM Stock Alerts

Carisma Therapeutics (CARM) SEC Filings & 10K Form

Carisma Therapeutics logo
$0.46 -0.04 (-7.86%)
Closing price 01/31/2025 04:00 PM Eastern
Extended Trading
$0.47 +0.01 (+2.00%)
As of 01/31/2025 07:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Carisma Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
01/13/2025
6:00 AM		Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2024
7:35 AM		Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
6:35 AM		Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
6:39 AM		Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/01/2024
3:30 PM		Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics (Issuer)
Cheng Sohanya Roshan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/01/2024
3:31 PM		Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics (Issuer)
Cheng Sohanya Roshan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
3:30 PM		Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2024
3:49 PM		Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
6:42 AM		Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
6:37 AM		Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2024
6:30 AM		Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2024
3:30 PM		Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2024
6:15 PM		Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics (Issuer)
Scadden David (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/01/2024
6:16 PM		Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics (Issuer)
Thorell Marella (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/01/2024
6:17 PM		Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics (Issuer)
Scadden David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
6:19 PM		Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics (Issuer)
Thorell Marella (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
6:37 AM		Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2024
3:54 PM		Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics (Issuer)
Morrison Briggs (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:56 PM		Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics (Issuer)
ZWEIFACH SANFORD S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:40 PM		Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2024
6:05 PM		Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics (Issuer)
Kelly Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
6:06 PM		Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics (Issuer)
Klichinsky Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
6:08 PM		Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics (Issuer)
Morris Richard Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:30 PM		Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
3:32 PM		Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2024
6:39 PM		Carisma Therapeutics Inc. (Subject)
Carisma Therapeutics Inc. (Subject)
Carisma Therapeutics (Subject)
HealthCap VII, L.P. (Filed by)
Form SC 13D/A
05/09/2024
6:52 AM		Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
6:41 AM		Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
7:02 AM		Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
Form DEF 14A
04/29/2024
7:05 AM		Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
Form ARS
04/10/2024
7:00 AM		Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2024
5:58 PM		Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics (Issuer)
Hohneker John (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/01/2024
5:59 PM		Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics (Issuer)
Hohneker John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
7:47 AM		Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/01/2024
7:41 AM		Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics Inc. (Filer)
Carisma Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
3:30 PM		AbbVie Biotechnology Ltd (Filed by)
Carisma Therapeutics Inc. (Subject)
Carisma Therapeutics Inc. (Subject)
Carisma Therapeutics (Subject)
Form SC 13G
02/02/2024
3:52 PM		Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics (Issuer)
Kelly Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
3:53 PM		Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics (Issuer)
Klichinsky Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
3:53 PM		Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics Inc. (Issuer)
Carisma Therapeutics (Issuer)
Morris Richard Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
12:06 PM		Carisma Therapeutics Inc. (Subject)
Carisma Therapeutics Inc. (Subject)
Carisma Therapeutics (Subject)
Longview Innovation Corp. (Filed by)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:CARM) was last updated on 2/1/2025 by MarketBeat.com Staff
From Our Partners
Elon’s #1 AI Stock” SET TO SOAR
Forget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.
Behind the Markets | Sponsored
Will DeepSeek pop the AI bubble?
An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...
Chaikin Analytics | Sponsored
Better than Bitcoin – and potentially more profitable
The world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...
Brownstone Research | Sponsored
Did You See Trump’s Manhattan Project Bombshell?
This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...
Banyan Hill Publishing | Sponsored
Trump vs. Texas
Ever since Donald Trump won the election, U.S. states have been rushing to pass new currency rules. These r...
Stansberry Research | Sponsored
Turning Panic Into Opportunity
AI stocks were hammered on Jan. 27. That includes Nvidia, the undisputed leader in the artificial intellige...
Weiss Ratings | Sponsored
Vladimir Lenin was right…
The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...
Porter & Company | Sponsored
Will Elon trigger another AI flash crash?
AI continues to dominate financial headlines in 2025...
Altimetry | Sponsored